Targeting BCMA in Multiple Myeloma: Evidence-Based Guidance for Current and Near-Future Clinical Integration

Learn how experts apply practice-changing clinical data to integrate the use of BCMA-targeted agents for their patients with multiple myeloma with focused commentaries a healthcare professional resource and a module with downloadable slides.

Share

Program Content

Activities

Targeting BCMA in Multiple Myeloma: Module
Targeting BCMA in Multiple Myeloma: Evidence-Based Guidance for Current and Near Future Clinical Integration
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: April 04, 2022

Expires: April 03, 2023

Activities

Targeting BCMA in Multiple Myeloma: Slides
Targeting BCMA in Multiple Myeloma: Evidence-Based Guidance for Current and Near Future Clinical Integration
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 04, 2022

Expires: April 03, 2023

Activities

BCMA-Targeted Therapies for Multiple Myeloma
Current and Future Roles of BCMA-Targeted Therapies for Multiple Myeloma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: February 02, 2022

Expires: February 01, 2023

BCMA-Targeted Bispecific Antibodies in R/R MM
BCMA-Targeted Bispecific Antibodies: A New Approach for Relapsed/Refractory Multiple Myeloma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 14, 2022

Expires: April 13, 2023

Activities

BCMA-Targeted Therapies for R/R MM
Understanding BCMA-Targeted Therapies for Relapsed/Refractory Multiple Myeloma: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: May 02, 2022

Expires: May 01, 2023

Faculty

cover img faculity

Sagar Lonial, MD, FACP

Chair and Professor 
Department of Hematology and Medical Oncology
Anne and Bernard Gray Family Chair in Cancer
Chief Medical Officer
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia

cover img faculity

Nina Shah, MD

Professor of Clinical Medicine
Division of Hematology-Oncology
Department of Medicine
University of California, San Francisco
San Francisco, California

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Pfizer, Inc.